Investigational Drug Details
| Drug ID: | D220 |
| Drug Name: | MB12066 |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | DB11948 |
| DrugBank Description: | Lapachone has been used in trials studying the treatment of Cancer, Carcinoma, Advanced Solid Tumors, Head and Neck Neoplasms, and Carcinoma, Squamous Cell. |
| PubChem ID: | 3885 |
| CasNo: | 4707-32-8 |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | Retinol-binding protein 3 |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 2 terminated (NCT02029586: Lack of recruitment) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0023 | NCT02029586 | Phase 2 | Terminated | No Results Available | January 2013 | December 21, 2017 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|